BioMarin Pharmaceutical
BMRN
#1907
Rank
โ‚น921.62 B
Marketcap
โ‚น4,797
Share price
-0.78%
Change (1 day)
-14.38%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น54.28 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total debt is โ‚น54.28 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioMarin Pharmaceutical - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น51.70 B-43.32%
2023-12-31โ‚น91.22 B0.82%
2022-12-31โ‚น90.47 B11.57%
2021-12-31โ‚น81.09 B2.02%
2020-12-31โ‚น79.48 B29.79%
2019-12-31โ‚น61.24 B5.47%
2018-12-31โ‚น58.06 B-22.57%
2017-12-31โ‚น74.99 B61.52%
2016-12-31โ‚น46.42 B5.49%
2015-12-31โ‚น44.01 B8.02%
2014-12-31โ‚น40.74 B0.6%
2013-12-31โ‚น40.50 B112.42%
2012-12-31โ‚น19.06 B3.47%
2011-12-31โ‚น18.42 B8.93%
2010-12-31โ‚น16.91 B-26.66%
2009-12-31โ‚น23.06 B-15.49%
2008-12-31โ‚น27.29 B39.82%
2007-12-31โ‚น19.51 B91.01%
2006-12-31โ‚น10.21 B1.26%
2005-12-31โ‚น10.09 B-13.96%
2004-12-31โ‚น11.72 B106.1%
2003-12-31โ‚น5.69 B
2001-12-31โ‚น0.26 B6815.56%
2000-12-31โ‚น3.87 M-19.72%
1999-12-31โ‚น4.82 M13.49%
1998-12-31โ‚น4.25 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น3.03 B-94.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น2.28 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น27.56 B-49.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น2.293 T 4,125.35%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
โ‚น39.78 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น0.25 B-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA